Blue Water Life Science Advisors, LP Natera, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $103 Million
- Q3 2025
A detailed history of Blue Water Life Science Advisors, LP transactions in Natera, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 141,494 shares of NTRA stock, worth $28.9 Million. This represents 22.07% of its overall portfolio holdings.
Number of Shares
141,494
Previous 166,494
15.02%
Holding current value
$28.9 Million
Previous $28.1 Million
19.02%
% of portfolio
22.07%
Previous 22.26%
Shares
17 transactions
Others Institutions Holding NTRA
# of Institutions
752Shares Held
127MCall Options Held
1.13MPut Options Held
449K-
Vanguard Group Inc Valley Forge, PA12.4MShares$2.53 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.9MShares$2.44 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY11.6MShares$2.38 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.38 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.25MShares$869 Million2.96% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $19.8B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...